FDA
-
-
-
-
-
-
-
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
-
-
-
-
-
-
-
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
-
-
-
-
-
-
-
Envoy Medical Appoints Chas McKhann to Board of Directors
-
-
-
-
-
-
-
Envoy Medical receives three new patents for hearing implant technology
-
-
-
-
-
-
-
Envoy Medical prices $78 million public offering with milestone warrants
-
-
-
-
-
-
-
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
-
-
-
-
-
-
-
Envoy Medical receives Nasdaq listing extension until February 2026
-
330,175 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

